When cancer and work collide, the effects run both ways

From the Shankaran research group, Public Health Sciences Division

For many people in the United States, a cancer diagnosis brings a practical worry alongside the medical ones, which is whether they can keep their job. Most working adults get health insurance through an employer, so staying employed often decides whether someone can afford treatment. At the same time, treatment appointments and the side effects that follow can take up so many hours that holding onto steady work becomes a struggle, especially for people without protections such as paid sick leave.

In an editorial published in JCO Oncology Practice, Fred Hutch oncologists Dr. Veena Shankaran, Dr. Hannah Abrams and colleagues consider what a new study on paid sick leave reveals about the connection between work and cancer.

That study drew on the National Health Interview Survey, a long-running federal survey that asks Americans about their health and daily lives. Among more than 12,000 working cancer survivors, those who had paid sick leave were less likely to put off care because of cost and less likely to die from cancer or other causes. The study’s authors proposed that paid sick leave might help long-term survivors get preventive care, have new symptoms checked quickly and keep up with the follow-up scans and visits that doctors call surveillance. They also suggested that paid leave may signal other benefits the survey did not ask about, such as flexible schedules or a workplace where taking time off for medical appointments is considered normal. One important caveat is that participants described the benefits they had at the time of the survey, not the ones they had during their cancer treatment.

The editorial authors offer another explanation, describing the relationship between work and cancer as a two-way street. In their view, jobs affect cancer care, but a cancer diagnosis can also change the work people do. Survivors who have the financial freedom to choose may move toward work that protects their health, accepting lower pay in exchange for flexibility or passing up promising but risky career moves that could put their insurance at stake. The authors point out that the link between sick leave and survival lasted up to 15 years after diagnosis, a stage when checkups usually happen only once or twice a year. A few paid days off for those visits seem unlikely to explain longer survival on their own, so it may be that survivors with more wealth and options seek out workplaces that support their health over the long term.

Illustration of the bidirectional relationship between employment and cancer care.
Illustration shows the bidirectional relationship between employment and cancer care.

Earlier research supports this idea, showing that while few survivors take extended leave a year or more after treatment, many switch to flexible schedules, move to less demanding jobs, turn down promotions, or retire earlier than planned. The authors caution that the survey participants were a population that may have easier access to flexible work than most, as they were largely college educated and mostly not from racial and ethnic minority groups. People juggling several jobs or working in rigid roles may not be able to make the same choices.

The authors also suggest specific steps that could help patients stay employed. Federal law guarantees 12 weeks of family and medical leave, yet many diagnoses and treatment plans stretch well beyond that, so the authors encourage employers to consider longer protections. Employers who make accommodations during treatment are more than twice as likely to keep those employees afterward. Radiology centers and laboratories could offer evening and weekend hours, which would allow patients without flexible jobs to get care without missing work. Oncologists can help by talking openly with patients about work, offering administrative support with the paperwork needed to access workplace benefits, treating side effects such as neuropathy, a form of nerve damage that can cause numbness and tingling, and using telemedicine visits and careful scheduling to limit time away from the job.

The authors call for more data on what patients actually experience at work, on how career paths change over the long term for survivors and caregivers, and on how dependence on employer-sponsored insurance can keep people stuck in jobs they might otherwise leave. They also want to know whether sick leave affects access to clinical trials. Programs that only educate patients have shown little benefit in rigorous studies, while approaches involving multiple specialists or helping people regain the physical ability to work have shown some promise. For that reason, the authors argue that future research should involve patients, employers, and oncologists together rather than leaving the burden on patients alone.

With more than 5% of Americans having received a cancer diagnosis and many more serving as caregivers, the authors write that it is “far past time for all stakeholders to support workplace participation” for survivors who want or need to work. Paid sick leave, they argue, is one of the clearest places to start.


The editorial did not report specific funding for this work.

Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium Member Dr. Veena Shankaran contributed to this research.

Abrams, H., Segarra-Vazquez, B., Sathe, C., & Shankaran, V. (2026). Work and Cancer: A Two-Way Street. JCO Oncology Practice, OP2600740. Advance online publication.

Darya Moosavi

Science Spotlight writer Darya Moosavi is a postdoctoral research fellow within Johanna Lampe's research group at Fred Hutch. Darya studies the nuanced connections between diet, gut epithelium, and gut microbiome in relation to colorectal cancer using high-dimensional approaches.